Sarissa Capital Management LP - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 74 filers reported holding REPROS THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sarissa Capital Management LP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$970,000
-19.9%
1,001,0000.0%0.21%
-8.9%
Q4 2015$1,211,000
-85.6%
1,001,000
-11.6%
0.24%
-88.7%
Q3 2015$8,413,000
+3.9%
1,132,3670.0%2.08%
+11.5%
Q2 2015$8,096,000
-16.8%
1,132,3670.0%1.86%
-9.2%
Q1 2015$9,727,000
-13.8%
1,132,3670.0%2.05%
-48.6%
Q4 2014$11,290,000
+0.7%
1,132,3670.0%4.00%
-7.7%
Q3 2014$11,210,000
-35.4%
1,132,367
+12.9%
4.33%
-26.7%
Q2 2014$17,358,000
+74.5%
1,003,367
+79.0%
5.90%
+72.4%
Q1 2014$9,945,000
+18.3%
560,600
+22.0%
3.42%
+8.7%
Q4 2013$8,409,000459,5083.15%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders